136 related articles for article (PubMed ID: 38383162)
1. Non-metastatic colon cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatments, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, AFEF, and SFR).
Lecomte T; Tougeron D; Chautard R; Bressand D; Bibeau F; Blanc B; Cohen R; Jacques J; Lagasse JP; Laurent-Puig P; Lepage C; Lucidarme O; Martin-Babau J; Panis Y; Portales F; Taieb J; Aparicio T; Bouché O; ; ; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2024 May; 56(5):756-769. PubMed ID: 38383162
[TBL] [Abstract][Full Text] [Related]
2. Impact of the IDEA Collaboration Study Results on Clinical Practice in France for Patients With Stage III Colon Cancer: A National GERCOR - PRODIGE Survey.
Ouali K; Turpin A; Neuzillet C; Rousseau B; Garcia-Larnicol ML; Tournigand C; Samalin E; Taieb J; André T; Cohen R
Clin Colorectal Cancer; 2021 Mar; 20(1):79-83.e4. PubMed ID: 33281064
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR).
Veziant J; Bouché O; Aparicio T; Barret M; El Hajbi F; Lepilliez V; Lesueur P; Maingon P; Pannier D; Quero L; Raoul JL; Renaud F; Seitz JF; Serre AA; Vaillant E; Vermersch M; Voron T; Tougeron D; Piessen G; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2023 Dec; 55(12):1583-1601. PubMed ID: 37635055
[TBL] [Abstract][Full Text] [Related]
4. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
Phelip JM; Tougeron D; Léonard D; Benhaim L; Desolneux G; Dupré A; Michel P; Penna C; Tournigand C; Louvet C; Christou N; Chevallier P; Dohan A; Rousseaux B; Bouché O
Dig Liver Dis; 2019 Oct; 51(10):1357-1363. PubMed ID: 31320305
[TBL] [Abstract][Full Text] [Related]
5. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT).
Roth GS; Verlingue L; Sarabi M; Blanc JF; Boleslawski E; Boudjema K; Bretagne-Bignon AL; Camus-Duboc M; Coriat R; Créhange G; De Baere T; de la Fouchardière C; Dromain C; Edeline J; Gelli M; Guiu B; Horn S; Laurent-Croise V; Lepage C; Lièvre A; Lopez A; Manfredi S; Meilleroux J; Neuzillet C; Paradis V; Prat F; Ronot M; Rosmorduc O; Cunha AS; Soubrane O; Turpin A; Louvet C; Bouché O; Malka D
Eur J Cancer; 2024 May; 202():114000. PubMed ID: 38493667
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Zaanan A; Bouché O; Benhaim L; Buecher B; Chapelle N; Dubreuil O; Fares N; Granger V; Lefort C; Gagniere J; Meilleroux J; Baumann AS; Vendrely V; Ducreux M; Michel P;
Dig Liver Dis; 2018 Aug; 50(8):768-779. PubMed ID: 29886081
[TBL] [Abstract][Full Text] [Related]
7. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Locher C; Batumona B; Afchain P; Carrère N; Samalin E; Cellier C; Aparicio T; Becouarn Y; Bedenne L; Michel P; Parc Y; Pocard M; Chibaudel B; Bouché O;
Dig Liver Dis; 2018 Jan; 50(1):15-19. PubMed ID: 29174568
[TBL] [Abstract][Full Text] [Related]
8. Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
Delhorme JB; Villeneuve L; Bouché O; Averous G; Dohan A; Gornet JM; You B; Bibeau F; Dartigues P; Eveno C; Fontaine J; Kepenekian V; Pocard M; Rousset P; Quenet F; Mariani P; Glehen O; Goéré D
Dig Liver Dis; 2022 Jan; 54(1):30-39. PubMed ID: 34815194
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC).
Neuzillet C; Gaujoux S; Williet N; Bachet JB; Bauguion L; Colson Durand L; Conroy T; Dahan L; Gilabert M; Huguet F; Marthey L; Meilleroux J; de Mestier L; Napoléon B; Portales F; Sa Cunha A; Schwarz L; Taieb J; Chibaudel B; Bouché O; Hammel P; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2018 Dec; 50(12):1257-1271. PubMed ID: 30219670
[TBL] [Abstract][Full Text] [Related]
10. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
de Mestier L; Lepage C; Baudin E; Coriat R; Courbon F; Couvelard A; Do Cao C; Frampas E; Gaujoux S; Gincul R; Goudet P; Lombard-Bohas C; Poncet G; Smith D; Ruszniewski P; Lecomte T; Bouché O; Walter T; Cadiot G;
Dig Liver Dis; 2020 May; 52(5):473-492. PubMed ID: 32234416
[TBL] [Abstract][Full Text] [Related]
11. Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).
Moureau-Zabotto L; Vendrely V; Abramowitz L; Borg C; Francois E; Goere D; Huguet F; Peiffert D; Siproudhis L; Ducreux M; Bouché O
Dig Liver Dis; 2017 Aug; 49(8):831-840. PubMed ID: 28610905
[TBL] [Abstract][Full Text] [Related]
12. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
André T; Vernerey D; Mineur L; Bennouna J; Desrame J; Faroux R; Fratte S; Hug de Larauze M; Paget-Bailly S; Chibaudel B; Bez J; Dauba J; Louvet C; Lepere C; Dupuis O; Becouarn Y; Mabro M; Egreteau J; Bouche O; Deplanque G; Ychou M; Galais MP; Ghiringhelli F; Dourthe LM; Bachet JB; Khalil A; Bonnetain F; de Gramont A; Taieb J;
J Clin Oncol; 2018 May; 36(15):1469-1477. PubMed ID: 29620995
[TBL] [Abstract][Full Text] [Related]
13. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
Benech N; Bonvalot S; Dufresne A; Gangi A; Le Péchoux C; Lopez-Trabada-Ataz D; Meurgey A; Nicolas N; Orbach D; Penel N; Salas S; Saurin JC; Walter T; Lecomte T; Bouché O; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2022 Jun; 54(6):737-746. PubMed ID: 35508462
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI).
Blanc JF; Debaillon-Vesque A; Roth G; Barbare JC; Baumann AS; Boige V; Boudjema K; Bouattour M; Crehange G; Dauvois B; Decaens T; Dewaele F; Farges O; Guiu B; Hollebecque A; Merle P; Selves J; Aparicio T; Ruiz I; Bouché O; ; ; ; ; ; ; ; ;
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101590. PubMed ID: 33780876
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).
Gérard JP; André T; Bibeau F; Conroy T; Legoux JL; Portier G; Bosset JF; Cadiot G; Bouché O; Bedenne L;
Dig Liver Dis; 2017 Apr; 49(4):359-367. PubMed ID: 28179091
[TBL] [Abstract][Full Text] [Related]
17. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos J; Boukovinas I; Kakolyris S; Xynogalos S; Ziras N; Athanasiadis A; Androulakis N; Christopoulou A; Vaslamatzis M; Ardavanis A; Emmanouilides C; Bompolaki I; Kourousis C; Makrantonakis P; Christofyllakis C; Athanasiadis E; Kentepozidis N; Karampeazis A; Katopodi U; Anagnosopoulos A; Papadopoulos G; Prinarakis E; Kalisperi A; Mavroudis D; Georgoulias V
Ann Oncol; 2019 Aug; 30(8):1304-1310. PubMed ID: 31228203
[TBL] [Abstract][Full Text] [Related]
18. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
Grothey A; Sobrero AF; Shields AF; Yoshino T; Paul J; Taieb J; Souglakos J; Shi Q; Kerr R; Labianca R; Meyerhardt JA; Vernerey D; Yamanaka T; Boukovinas I; Meyers JP; Renfro LA; Niedzwiecki D; Watanabe T; Torri V; Saunders M; Sargent DJ; Andre T; Iveson T
N Engl J Med; 2018 Mar; 378(13):1177-1188. PubMed ID: 29590544
[TBL] [Abstract][Full Text] [Related]
19. FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
Sobrero A; Lonardi S; Rosati G; Di Bartolomeo M; Ronzoni M; Pella N; Scartozzi M; Banzi M; Zampino MG; Pasini F; Marchetti P; Cantore M; Zaniboni A; Rimassa L; Ciuffreda L; Ferrari D; Zagonel V; Maiello E; Barni S; Rulli E; Labianca R;
J Clin Oncol; 2018 May; 36(15):1478-1485. PubMed ID: 29620994
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Oxaliplatin in Stage III Colon Cancer According to IDEA Risk Groups: Findings from the ACCENT Database of 4934 Patients.
Margalit O; Boursi B; Rakez M; Thierry A; Yothers G; Wolmark N; Haller DG; Schmoll HJ; Shi Q; Shacham-Shmueli E; de Gramont A
Clin Colorectal Cancer; 2021 Jun; 20(2):130-136. PubMed ID: 33775561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
